WCN25-3322 BARTTER’S SYNDROME TYPE II DUE TO A NOVEL MUTATION IN KCNJ1 GENE PRESENTING IN ADULTHOOD AS RECURRENT HYPOKALAEMIC PERIODIC PARALYSIS
treatments.We believe that this innovative formulation may improve compliance with long-term treatment and reduce nephrocalcinosis and nephrolithiasis as well as the consequences of hypokalemia.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Authors
- Sharon Kandari (ORCID: https://orcid.org/0000-0002-5411-5837)
- Rohit Puri
Institutions
- Seema Dental College and Hospital (IN)
- All India Institute of Medical Sciences Rishikesh (IN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.082
- Primary Topic
- Ion Transport and Channel Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00